Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
Apr 1, 2026, 4:00 PM EST
Affymax Market Cap
Affymax has a market cap or net worth of $74.49 thousand as of April 2, 2026. Its market cap has decreased by -75.00% in one year.
Market Cap
74.49K
Enterprise Value
n/a
Revenue
42.00K
Ranking
n/a
PE Ratio
0.01
Stock Price
$0.00
Market Cap Chart
Since December 15, 2006, Affymax's market cap has decreased from 484.83M to 74.49K, a decrease of -99.98%. That is a compound annual growth rate of -36.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 74.49K | 25.00% |
| Dec 31, 2025 | 59.59K | - |
| Dec 31, 2024 | 59.59K | 33.33% |
| Dec 29, 2023 | 44.69K | -85.00% |
| Dec 30, 2022 | 297.96K | -33.33% |
| Dec 31, 2021 | 446.94K | -94.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxxinity | 126.75K |
| GlobeStar Therapeutics | 124.11K |
| Immunotech Laboratories | 114.99K |
| CNBX Pharmaceuticals | 112.58K |
| Synairgen | 110.27K |
| PaxMedica | 88.39K |
| Sigyn Therapeutics | 76.29K |
| Vincerx Pharma | 66.48K |